Header Logo

Connection

MICHAEL GILCREASE to Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications MICHAEL GILCREASE has written about Enzyme Inhibitors.
MICHAEL GILCREASE
Connection Strength
0.096
Enzyme Inhibitors
  1. Role of RPL39 in Metaplastic Breast Cancer. J Natl Cancer Inst. 2017 06; 109(6).
    View in: PubMed
    Score: 0.085
  2. Phosphorylated galectin-3 mediates tumor necrosis factor-related apoptosis-inducing ligand signaling by regulating phosphatase and tensin homologue deleted on chromosome 10 in human breast carcinoma cells. J Biol Chem. 2007 Jul 20; 282(29):21337-48.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.